A novel predictive score for hepatocellular carcinoma development in patients with chronic hepatitis C after sustained response to pegylated interferon and ribavirin combination therapy

Journal of Antimicrobial Chemotherapy ◽

10.1093/jac/dks269 ◽

2012 ◽

Vol 67 (11) ◽

pp. 2766-2772 ◽

Author(s):

K.-C. Chang ◽

C.-H. Hung ◽

S.-N. Lu ◽

J.-H. Wang ◽

C.-M. Lee ◽

...

Keyword(s):

Hepatocellular Carcinoma ◽

Chronic Hepatitis ◽

Hepatitis C ◽

Combination Therapy ◽

Chronic Hepatitis C ◽

Pegylated Interferon ◽

Sustained Response ◽

Predictive Score

Download Full-text

1097 INDEPENDENT RISK FACTORS AND PREDICTIVE SCORE FOR THE DEVELOPMENT OF HEPATOCELLULAR CARCINOMA IN CHRONIC HEPATITIS C AFTER SUSTAINED RESPONSE TO PEGINTERFERON AND RIBAVIRIN COMBINATION THERAPY

Journal of Hepatology ◽

10.1016/s0168-8278(12)61109-x ◽

2012 ◽

Vol 56 ◽

pp. S432

Author(s):

K.-C. Chang ◽

C.-M. Lee ◽

S.-N. Lu ◽

J.-H. Wang ◽

C.-H. Hung ◽

...

Keyword(s):

Risk Factors ◽

Hepatocellular Carcinoma ◽

Chronic Hepatitis ◽

Hepatitis C ◽

Combination Therapy ◽

Chronic Hepatitis C ◽

Sustained Response ◽

Predictive Score ◽

Independent Risk Factors ◽

Peginterferon And Ribavirin

Download Full-text

Risk factors for development of hepatocellular carcinoma in patients with chronic hepatitis C without sustained response to combination therapy

Journal of the Formosan Medical Association ◽

10.1016/j.jfma.2017.11.008 ◽

2018 ◽

Vol 117 (11) ◽

pp. 1011-1018 ◽

Author(s):

Kuo-Chin Chang ◽

Yi-Hao Ye ◽

Cheng-Kun Wu ◽

Ming-Tsung Lin ◽

Ming-Chao Tsai ◽

...

Keyword(s):

Risk Factors ◽

Hepatocellular Carcinoma ◽

Chronic Hepatitis ◽

Hepatitis C ◽

Combination Therapy ◽

Chronic Hepatitis C ◽

Sustained Response

Download Full-text

Hepatocellular carcinoma in a long-term sustained virological responder following pegylated-interferon plus ribavirin combination therapy for chronic hepatitis C

International Journal of Infectious Diseases ◽

10.1016/j.ijid.2014.03.1065 ◽

2014 ◽

Vol 21 ◽

pp. 311

Author(s):

E. Gunal ◽

M.K. Celen

Keyword(s):

Hepatocellular Carcinoma ◽

Chronic Hepatitis ◽

Hepatitis C ◽

Combination Therapy ◽

Chronic Hepatitis C ◽

Pegylated Interferon ◽

Sustained Virological Responder ◽

Pegylated Interferon Plus Ribavirin

Download Full-text

The efficacy and safety of pegylated interferon plus ribavirin combination therapy in chronic hepatitis c patients with hepatocellular carcinoma post curative therapies – A multicenter prospective trial

Journal of Hepatology ◽

10.1016/j.jhep.2010.07.011 ◽

2011 ◽

Vol 54 (2) ◽

pp. 219-226 ◽

Author(s):

Jee-Fu Huang ◽

Ming-Lung Yu ◽

Chung-Feng Huang ◽

Chang-Fu Chiu ◽

Chia-Yen Dai ◽

...

Keyword(s):

Hepatocellular Carcinoma ◽

Chronic Hepatitis ◽

Hepatitis C ◽

Combination Therapy ◽

Chronic Hepatitis C ◽

Prospective Trial ◽

Pegylated Interferon ◽

Efficacy And Safety ◽

Pegylated Interferon Plus Ribavirin ◽

Chronic Hepatitis C Patients

Download Full-text

Occurrence of Diffuse, Poorly Differentiated Hepatocellular Carcinoma During Pegylated Interferon Plus Ribavirin Combination Therapy for Chronic Hepatitis C

Journal of Chemotherapy ◽

10.1179/joc.2008.20.3.380 ◽

2008 ◽

Vol 20 (3) ◽

pp. 380-384

Author(s):

M. Capanni ◽

E. Lorefice ◽

M.C. Benini ◽

M.R. Biagini ◽

A. Tozzi ◽

...

Keyword(s):

Hepatocellular Carcinoma ◽

Chronic Hepatitis ◽

Hepatitis C ◽

Combination Therapy ◽

Chronic Hepatitis C ◽

Pegylated Interferon ◽

Pegylated Interferon Plus Ribavirin ◽

Poorly Differentiated

Download Full-text

Predictors of alpha-fetoprotein elevation in patients with chronic hepatitis C, but not hepatocellular carcinoma, and its normalization after pegylated interferon alfa 2a-ribavirin combination therapy

Journal of Gastroenterology and Hepatology ◽

10.1111/j.1440-1746.2007.04898.x ◽

2007 ◽

Vol 22 (5) ◽

pp. 669-675 ◽

Author(s):

Tsung-Ming Chen ◽

Pi-Teh Huang ◽

Ming-Hung Tsai ◽

Lien-Fu Lin ◽

Chung-Cheng Liu ◽

...

Keyword(s):

Hepatocellular Carcinoma ◽

Chronic Hepatitis ◽

Hepatitis C ◽

Combination Therapy ◽

Chronic Hepatitis C ◽

Pegylated Interferon ◽

Interferon Alfa ◽

Alpha Fetoprotein ◽

Pegylated Interferon Alfa

Download Full-text

408 RISK FACTORS FOR DEVELOPMENT OF HEPATOCELLULAR CARCINOMA IN PATIENTS WITH CHRONIC HEPATITIS C AFTER SUSTAINED RESPONSE TO PEGINTERFERON AND RIBAVIRIN COMBINATION THERAPY

Journal of Hepatology ◽

10.1016/s0168-8278(11)60410-8 ◽

2011 ◽

Vol 54 ◽

pp. S164

Author(s):

K.-C. Chang ◽

T.-H. Hu

Keyword(s):

Risk Factors ◽

Hepatocellular Carcinoma ◽

Chronic Hepatitis ◽

Hepatitis C ◽

Combination Therapy ◽

Chronic Hepatitis C ◽

Sustained Response ◽

Peginterferon And Ribavirin

Download Full-text

Prediction of sustained virologic responses to combination therapy of pegylated interferon-α and ribavirin in patients with chronic hepatitis C infection

Journal of Family and Community Medicine ◽

10.4103/2230-8229.108182 ◽

2013 ◽

Vol 20 (1) ◽

pp. 35 ◽

Author(s):

MonaH Ismail

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Combination Therapy ◽

Chronic Hepatitis C ◽

Pegylated Interferon ◽

Interferon Α ◽

Hepatitis C Infection

Download Full-text

360 CXCL10 GENE POLYMORPHISM PREDICTS RAPID VIROLOGIC RESPONSE TO PEGYLATED INTERFERON/RIBAVIRIN COMBINATION THERAPY IN ASIAN PATIENTS WITH DIFFICULT-TO-TREAT CHRONIC HEPATITIS C GENOTYPE

Journal of Hepatology ◽

10.1016/s0168-8278(13)60362-1 ◽

2013 ◽

Vol 58 ◽

pp. S149

Author(s):

K. Thanapirom ◽

S. Suksawatamnuay ◽

P. Tangkijvanich ◽

S. Treeprasertsuk ◽

Y. Poovorawan ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Combination Therapy ◽

Gene Polymorphism ◽

Chronic Hepatitis C ◽

Pegylated Interferon ◽

Virologic Response ◽

Rapid Virologic Response ◽

Download Full-text

Pegylated interferon-α2b and ribavirin combination therapy for pediatric patients with chronic hepatitis C

Kanzo ◽

10.2957/kanzo.49.386 ◽

2008 ◽

Vol 49 (8) ◽

pp. 386-388 ◽

Author(s):

Ayano Inui ◽

Haruki Komatsu ◽

Tsuyoshi Sogo ◽

Takuji Hashimoto ◽

Tomoo Fujisawa

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Combination Therapy ◽

Chronic Hepatitis C ◽

Pediatric Patients ◽

Pegylated Interferon ◽

Interferon Α2b

Download Full-text